MTPConnect بودكاست

The Targeted Translation Research Accelerator (TTRA) program, a Medical Research Future Fund initiative delivered by MTPConnect, launched Round 3 of its Research Projects funding opportunity on 30 January 2023 to support diabetes and cardiovascular disease projects that address the unmet health and medical needs of Aboriginal and Torres Strait Isla…

It’s three years ago this month that COVID-19 was declared a pandemic by the World Health Organisation. We’ve seen nearly 800 million confirmed cases around the world and nearly 7 million deaths… and there are signs that another wave is underway in Australia as we head into the colder months. But imagine those numbers if we didn’t have the vaccines…

Our Targeted Translation Research Accelerator (TTRA) program, a Medical Research Future Fund initiative delivered by MTPConnect, launched Round 3 of its Research Projects funding opportunity in January 2023 to support diabetes and cardiovascular disease projects that address the unmet health and medical needs of Aboriginal and Torres Strait Islande…

We talk to Sydney-based eye surgeon Dr Sarah Crowe, Founder and Director of 4eyesVision who has invented the 4eyesVision Kit to correct refractive error, the leading cause of blindness in the developing world and provide affordable glasses on the spot for people in remote and developing communities. Dr Crowe shares her clinician entrepreneur story …

MTPConnect’s Targeted Translation Research Accelerator (TTRA) program has opened a new funding round to support diabetes and cardiovascular disease research projects that address the unmet health and medical needs of Aboriginal and Torres Strait Islander peoples in rural, remote, regional, and urban centres. To develop this Indigenous-specific roun…

For this episode we tap into an international perspective on the digital health sector and the business of healthcare. Lisa Suennen is a US-based entrepreneur and industry advisor. After thirty years in healthcare and seeing little progress in efficiency and optimisation of care, she moved into the digital health space, working as a venture capital…

Australian company Minomic has developed the MiCheck Prostate blood test that uses an algorithm, together with other biomarkers, to estimate the risk of a patient having aggressive prostate cancer. The diagnostic overcomes the low accuracy of conventional screening tests to reduce unnecessary intervention such as painful biopsies and improve overal…

MTPConnect’s Targeted Translation Research Accelerator (TTRA) program will open Round 3 of its Research Projects funding opportunity in early 2023 to support diabetes and cardiovascular disease projects that address the unmet health and medical needs of Aboriginal and Torres Strait Islander peoples in rural, remote, regional, and urban centres. In …

It’s World Antimicrobial Awareness Week and this year’s theme is “Preventing Antimicrobial Resistance Together”. We chat to Bugworks, a clinical stage pharmaceutical company, headquartered in the US, with subsidiaries in India and Australia, currently developing novel antibacterials and immunotherapies. Bugworks’ Co-founder and Chief Executive Offi…

MTPConnect hits The MedTech Conference in Boston, USA, leading a delegation of 18 Australian companies to showcase Australia’s outstanding innovative medical technologies and capabilities to the world’s largest medtech market. With the creation of the unmissable Australian Pavilion exhibit and a top-level visit program of keynotes and networking ev…

MTPConnect hits The MedTech Conference in Boston, USA, leading a delegation of 18 Australian companies to showcase Australia’s outstanding innovative medical technologies and capabilities to the world’s largest medtech market. With the creation of the unmissable Australian Pavilion exhibit and a top-level visit program of keynotes and networking ev…

CSIRO’s year-round Kick-Start program has helped over 200 early-stage start-ups and small businesses pursue R&D activities by providing access to CSIRO research and capability. This includes help with articulating a company’s research question, connecting businesses with relevant CSIRO researchers and fifty per cent matched funding support to impro…

Inventia Skin is a Sydney-based start-up on a mission to revolutionise wound repair by developing Ligō, a skin printing robot. It delivers rapid and precise regenerative cellular therapy products directly onto a wound and could help to treat difficult to heal skin burns. A number of partners - high profile scientists and physicians - are lending th…

Back in May 2019, MTPConnect launched the Biomedical Translation Bridge (BTB) program, a $22.3 million initiative of the Medical Research Future Fund, supporting the translation of new therapies, technologies and medical devices through to the proof-of-concept stage. In a first for Australia, it did that by pairing funded projects with industry men…

MTPConnect is delivering the MRFF-funded $19.75 million Clinical Translation and Commercialisation Medtech (CTCM) program to support the development of home-grown medical devices. The program has opened its second and final funding round calling for applications from Australian small to medium-sized enterprises (SMEs) developing medical device proj…

Back in May 2019, MTPConnect launched the Biomedical Translation Bridge (BTB) program, a $22.3 million initiative of the Medical Research Future Fund, supporting the translation of new therapies, technologies and medical devices through to the proof-of-concept stage. In a first for Australia, it did that by pairing funded projects with industry men…

The Australian Centre for Health Services Innovation (AusHSI) is a leading health services research centre, based at the Queensland University of Technology (QUT) within the Faculty of Health. The Centre is working with our Targeted Translation Research Accelerator Program providing support and mentoring to TTRA applicants and awardees with standal…

Professor Marshall is a celebrated vaccination researcher, who has been named the 2022 South Australia Australian of the Year. Her work in vaccinology, public health and infectious diseases at the University of Adelaide’s Robinson Research Institute has focused on protecting babies and children from Meningococcal disease. She led the world’s larges…

Antimicrobial resistance (AMR) has been described as a ‘silent pandemic’, and now takes more lives than malaria and HIV globally, and in Australia, over 1,600 deaths were attributed to AMR in 2019. CARB-X (Combating Antibiotic-Resistant Bacteria Biopharmaceutical Accelerator) is a global non-profit partnership focused on supporting antibacterial re…

As new COVID-19 variants are detected in Australia and a wave of COVID cases spike again, researchers at the University of Sydney have teamed up with an international consortium to develop a low-cost variant proof COVID-19 vaccine with the help of US $19.3 million funding from The Coalition for Epidemic Preparedness Innovations. To tell us more abo…

Heart attack caused by rupture of unstable plaque in the coronary arteries is the number one cause of death worldwide. Melbourne-based medtech company Nirtek, is using laser technology discovered at the Baker Heart and Diabetes Institute, to develop the first intra-coronary guidewire device for the detection of unstable plaque to prevent heart atta…

As the world’s largest Biotech convention, BIO 2022, gets underway in San Diego California after a 2 year hiatus due to pandemic restrictions, MTPConnect’s team is on the ground promoting Australian companies at the Australian Pavilion (led by AusBiotech) and attending various events and meetings. In this pacey compilation, MTPConnect CEO Stuart Di…

The last few years have been dominated by the global fight against COVID-19 and research efforts continue in search of new treatments and vaccines to save lives. Melbourne-based Dimerix Bioscience is a clinical-stage biopharmaceutical company investigating a new treatment for respiratory complications as a result of COVID 19 – which was selected fo…

Around the world, approximately 16,500 people die from sudden cardiac arrest every day due to delayed access to a defibrillator. We speak with Donovan Casey, co-founder, CEO and Executive chairman of Rapid Response Revival, a Sydney based medical technology startup hoping to improve these odds of survival by developing CellAED - a life-saving porta…

Is your startup on a mission to address a major public health challenge? Do you need the know-how, guidance and connections to get investment-ready and rapidly grow? MTPConnect co-hosts Caroline Duell and Dr Duncan Macinnis, Director Stakeholder Engagement for NSW and ACT, look into the unique Health 10X Accelerator delivered by the George Institut…

We speak to Robert Yearsley, CEO and co-founder of ARIA Research, a company developing a new medical device - a non-surgical and non-invasive Electronic Vision Aid in the form of a pair of glasses - which enables blind and vision-impaired people to see through sound. ARIA has been developed in collaboration with University of Sydney, University of …

In the first face-to-face podcast interview since January 2020, we speak with Dr Mat McGann, co-founder and CEO of Health Horizon, a health innovation tracking and discovery platform - making it easy to follow the progress of medical innovations around the world. MTPConnect supported Health Horizon's development through the Growth Centre Project Fu…

The show takes a look at how we can take more great Australian science from the lab bench into the boardroom. And create companies, jobs and products. Joining the podcast is Misha Schubert, Chief Executive Officer at Science & Technology Australia and Professor Mark Hutchinson, the new President at Science & Technology Australia. Science & Technolo…

The Clinical Translation and Commercialisation - Medtech (CTCM) program, delivered by MTPConnect, is offered under the 2020 Early Stage Translation and Commercialisation Support Grant of the Medical Research Future Fund's Medical Research Commercialisation Initiative. The $19.75 million CTCM program is targeting Australian small to medium-sized ent…

We get an update on the development of Australia’s world-first Bionic Eye System. Similar to Cochlear’s bionic ear, it involves a visual implant to give functional vision to people who’ve lost their sight due to the genetic condition, Retinitis Pigmentosa. The consortium behind this innovation, which has just been granted a Breakthrough Device desi…

For our first episode of 2022, we look into a new partnership between Perth-based oligonucleotides manufacturer SynGenis and Sydney-based diagnostic company SpeeDx. WA start-up SynGenis is the brainchild of Professor Rakesh Veedu, a world-renowned oligonucleotide chemical biologist. Sydney-based SpeeDx, led by CEO Colin Denver, is a privately owned…

Episode 118. Ancient and New: WA’s Cliniface and Lyfe Languages Improving Indigenous Healthcare Through Technology The podcast visits Western Australia to find out how new technology like Artificial Intelligence is being used to improve healthcare for Indigenous Australians and those living in remote communities. Cliniface is delivering the world’s…

It’s World Antimicrobial Awareness Week and we are shining a light on Australia’s expertise and innovations to fight superbugs. In this episode, hosts Caroline Duell and Dr Rebecca Tunstall, MTPConnect’s Senior Director of Stakeholder Engagement, catch up with BiomeBank, a company out of South Australia. As Australia's first public stool bank and a…

It’s World Antimicrobial Awareness Week 2021 and we are shining a light on Australia’s expertise and innovations to fight superbugs. In this episode we catch up with Recce Pharmaceuticals, a company out of Western Australia that is pioneering the development and commercialisation of a new class of synthetic anti-infectives designed to overcome resi…

It’s World Antimicrobial Awareness Week and we are shining a light on Australia’s expertise and innovations to fight antimicrobial resistance (AMR) and superbugs. In this episode, we catch up with LBT Innovations, a groundbreaking South Australian company designing advanced medical technologies that automate culture plate reading and improve medica…

It’s World Antimicrobial Awareness Week 2021 and we are shining a light on Australia’s expertise and innovations to fight antimicrobial resistance (AMR) and superbugs. Joining our podcast host Caroline Duell is MTPConnect’s Director of Stakeholder Engagement for Queensland Andrew Bowskill, who is the co-chair of AAMRNet, Australia’s first industry …

We catch up with medtech start-up Coviu, the company behind a game-changing video telehealth software that is now being used by 65,000+ health professionals in Australia. Coviu recently took out two awards at the Australian Technologies Competition (ATC), an accelerator program that MTPConnect supports in partnership with the Australian Government’…

The Targeted Translation Research Accelerator (TTRA) initiative for diabetes and cardiovascular disease, supported by the Medical Research Future Fund, is providing a new integrated research program to improve the prevention, diagnosis, treatment and management of diabetes and cardiovascular disease (D&CVD) in Australia. The TTRA is calling for Exp…

Dr Maheshi Ramasamy is a Principal Investigator at the Oxford Vaccine Group where she leads on adult clinical vaccine trials including the Oxford AstraZeneca COVID-19 vaccine trials. Dr Ramasamy joins the podcast from the UK to take us through the challenges of developing a successful international clinical trial against the clock during a fast-mov…

A South Australian start-up biotech company, Sementis Limited, has joined the global quest to develop a second-generation COVID-19 vaccine using their proprietary viral-vector vaccine platform technology, in partnership with the University of South Australia. The vaccine candidate is anticipated to be effective against mutant strains of COVID-19. T…

GSK Australia has developed the GSK Graduate Researcher Program, with support from MTPConnect’s Researcher Exchange and Development within Industry (REDI) initiative. The multinational pharmaceutical company gives PhD postgraduates a 12-month placement assigning them to lead on core projects in areas such as early product development, medical affai…

Australian company Synchron has developed a brain chip called the Stentrode that helps people with paralysis communicate by controlling digital devices with their thoughts. The groundbreaking medical device is implanted into the motor cortex without open brain surgery. It has been trialed successfully with several Australian patients and is the fir…

Australian MedTech startup, Vantari VR, has developed a virtual reality technology-based on flight simulation for medical training. It’s already being used to teach life-saving medical procedures in several Australian hospitals. The technology is so good it’s attracted funding from one of the world’s largest video game developers! Dr Nishanth (Nish…

Strep A is a highly contagious bacteria responsible for more than half a million deaths every year and is developing resistance to antibiotics. In Australia, diseases caused by Strep A, such as rheumatic fever and rheumatic heart disease, disproportionately affect Aboriginal and Torres Strait Islander communities. The good news is an Australian led…

In this episode, we take you to our recent Collaboration and Skills Summit where we brought together a panel of industry experts to share their tips and experiences on how to maximise virtual partnering success at biotech conferences and meetings. You will hear from Colin Denver, CEO of SpeeDx Pty Ltd, an Australian diagnostics company developing t…

In this episode, we take you to the launch of our new report into Australia’s Clinical Trials sector held on International Clinical Trials Day in Melbourne. MTPConnect brought together a panel of thought leaders to discuss the importance of clinical trials. Hear insights from our esteemed panel chaired by Dr Dan Grant, MTPConnect's Managing Directo…

In this episode we take you to our recent Collaboration and Skills Summit where we brought together a panel of industry experts to share their tips and experiences on how to maximise virtual partnering success at biotech conferences and meetings. You will hear from Dr Nina Webster, the Managing Director & CEO of Dimerix Limited who shares the highs…

This week’s edition of the MTPConnect podcast checks in with the Australian Technology Competition - Australia's national Competition, late-stage accelerator and partnerships program designed to identify and accelerate homegrown scaleups with global potential. Last year, Electrogenics Laboratories won the Australian Technology Company of the Year a…

Tune in for part 2 of our 100th episode special, following our chat with Professor Kate Schroder, head of the Inflammasome Laboratory and Director of the Centre for Inflammation and Disease Research at the Institute for Molecular Bioscience (IMB), University of Queensland and Professor Ian Henderson, the Director of IMB. We explore the story behind…

Happy 100th episode subscribers! We bring you part 1 of a special double episode following our chat with Professor Kate Schroder, head of the Inflammasome Laboratory and Director of the Centre for Inflammation and Disease Research at the Institute for Molecular Bioscience (IMB), University of Queensland and Professor Ian Henderson, the Director of …